More on BMY by Philip Davis
Latest BMY Articles
-
Johnson & Johnson: An Uncommon Opportunity
Thu, May 24 • Rajiv Tarigopula
-
4 Large Cap Dividend Stocks With Strong Profits That Analysts Rate As Buy
Thu, May 24 • ZetaKap
-
Report Card: Johnson & Johnson And Selected Peers
Tue, May 22 • Steven Bauer
-
Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals
Tue, May 22 • Timeless Wealth
-
Hints Of A Market Collapse In The Western World
Tue, May 22 • Dutch Trader
-
Teva's New CEO: A Positive Catalyst Going Forward
Mon, May 21 • Daniel Shvartsman
-
Building A Euro-Proof Portfolio: Part II
Mon, May 21 • Bret Kenwell
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Bristol-Myers Squibb Company (BMY)
Posts on BMY by Philip Davis
The Calm Before the Storm – Big Pharma Is Gonna Have Big Problems and Pfizer is the BIGGEST
Posts on BMY by other instabloggers
-
Mon, May 14
•
Dividends4Life
-
Thu, May 10
•
OPursche
-
Thu, May 3
•
Dividend Sheet
-
Thu, Apr 26
•
Jim Van Meerten
-
Mon, Apr 9
•
Charles Margolis
All instablog posts on BMY »Johnson & Johnson (JNJ) Dividend Stock Analysis
Seven Stock Screens For Success
An Overview Of The Safest Large Cap Dividend Stocks
Barchart Moring Call 4/26
Obamacare: Medical Management Without Medicine